Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01998035
What this trial is testing

Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies

Who this might be right for
Lymphoid MalignanciesLymphomaHodgkin Lymphoma+1 more
Columbia University 58
Early research (Phase 1)Study completedNCT01886859
What this trial is testing

Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Recurrent B-Cell Prolymphocytic LeukemiaRecurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+3 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT03206918
What this trial is testing

Efficacy and Safety of Zanubrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Relapsed or Refractory Chronic Lymphocytic LeukemiaRelapsed or Refractory Small Lymphocytic Lymphoma
BeiGene 91
Testing effectiveness (Phase 2)Study completedNCT01744691
What this trial is testing

Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion

Who this might be right for
Chronic Lymphocytic Leukemia With 17p DeletionSmall Lymphocytic Lymphoma With 17p Deletion
Pharmacyclics LLC. 145
Early research (Phase 1)Study completedNCT04155710
What this trial is testing

Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Iovance Biotherapeutics, Inc. 7
Early research (Phase 1)Study completedNCT00068315
What this trial is testing

Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueHematopoietic/Lymphoid CancerNodal Marginal Zone B-cell Lymphoma+9 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Ended earlyNCT01744912
What this trial is testing

Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies

Who this might be right for
Non-Hodgkins LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma+4 more
TG Therapeutics, Inc. 10
Early research (Phase 1)Ended earlyNCT03624036
What this trial is testing

Study to Evaluate the Safety and Tolerability of Brexucabtagene Autoleucel (KTE-X19) in People With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Who this might be right for
Relapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic Lymphoma
Kite, A Gilead Company 16
Early research (Phase 1)Ended earlyNCT00004239
What this trial is testing

506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Alliance for Clinical Trials in Oncology 10
Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT07024706
What this trial is testing

Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
AstraZeneca 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06979076
What this trial is testing

A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL

Who this might be right for
CLL (Chronic Lymphocytic Leukemia)SLL (Small Lymphocytic Lymphoma)
MingSight Pharmaceuticals, Inc 12
Testing effectiveness (Phase 2)Study completedNCT00002908
What this trial is testing

Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT02265731
What this trial is testing

Study Evaluating Venetoclax in Subjects With Hematological Malignancies

Who this might be right for
Non-Hodgkin Lymphoma (NHL)Multiple Myeloma (MM)Chronic Lymphocytic Leukemia (CLL)+2 more
AbbVie 38
Testing effectiveness (Phase 2)Study completedNCT00003396
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore 42
Testing effectiveness (Phase 2)Study completedNCT00436618
What this trial is testing

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Mayo Clinic 277
Early research (Phase 1)Study completedNCT04434196
What this trial is testing

A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Celgene 16
Early research (Phase 1)Study completedNCT02242045
What this trial is testing

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic LeukemiaIndolent Non-Hodgkin LymphomaFollicular Lymphoma+3 more
Gilead Sciences 6
Early research (Phase 1)Ended earlyNCT00014560
What this trial is testing

Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Dartmouth-Hitchcock Medical Center 3
Testing effectiveness (Phase 2)Study completedNCT00611351
What this trial is testing

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+4 more
University of Nebraska 5
Next Page